Life Sciences & Healthcare Translation & Content Services

Name: Life Sciences Translation Services for Regulated Markets
Brand: Acolad

MedTech, Pharma, Biotech and CRO teams operate under regulatory scrutiny in every market they enter. From clinical development to post-market surveillance, we ensure your documentation stays accurate, traceable and on time.

Talk to an Expert

Ranked #1
CSA Research, Life Sciences

500+ language pairs
All major regulated markets

30+ Years
Life sciences expertise

Clinical Trial Translation

Keep Studies on Schedule

For Clinical Operations, Clinical Affairs and COA teams across MedTech, Pharma and CROs

Clinical documentation delays push back study timelines and regulatory windows. Trial teams need content that is precise, coordinated, and approved at site level in every required language.

Study protocols and ICFs
Investigator materials and site communications
eCOA and ePRO content

Secure Market Approval

For Regulatory Affairs, Labeling, QA and Compliance teams

A submission gets your product to market. Consistent post-approval content is what keeps it there. A single inconsistency in a dossier can trigger a deficiency notice or compromise market access in a key region.

MDR and IVDR technical documentation
Submission dossiers across EMA, FDA, PMDA, NMPA
Labeling that holds across markets

Post-Market Translation

Scale with Confidence

For Pharmacovigilance, Drug Safety, PMS and Vigilance teams

Post-market obligations move on regulator timelines, not yours. Safety reporting, complaint handling and vigilance documentation must be processed at scale, in every required language, with no break in version history.

PSURs and DSURs
ICSRs and SUSAR narratives
PMS reports for Medical Devices

Quality Built Into Every Workflow

Every document is traceable, versioned and review-documented. Your team walks into any audit with a complete, defensible paper trail.

life-sciences-doctor-research-square-fade

Regulatory awareness

across GxP, MDR and IVDR frameworks

Validated, SOP-driven workflows

for every regulated program

Dedicated Life Sciences specialists

on every regulated program

Compliance-trained project managers

supporting FDA, EMA and global regulatory workflows

Multilingual Compliance for Medical Devices

MedTech organizations under MDR and IVDR face mounting pressure to keep IFUs accurate, labels consistent and technical files defensible across every market. Structured multilingual workflows built around version control and regulatory traceability keep global launches on schedule.

MDR readiness
IFU accuracy at scale
Global product launch coordination
Controlled version management

Regulatory Localization for Pharmaceutical Teams

Pharmaceutical teams expanding across regions cannot afford label discrepancies or submission gaps. Governance-driven processes keep dossiers harmonized and regulatory alignment maintained across markets.

Submission harmonization
Label consistency
Multi-market regulatory alignment
Scalable pharmacovigilance support

Multilingual Support for Clinical Trials and Site Operations

CROs running multi-country studies face a documentation challenge that compounds with every new site. Structured coordination and centralized content control keep study timelines intact, regardless of volume or geographic scope.

Multi-country coordination
High-volume documentation control
System integration
Operational scalability

doctor holding tablet speaking with patient

The Acolad Clinical Center of Excellence

Partner with our language specialists to simplify complex trials and ensure project quality.

From clinical development to post-market activities, ensure your documentation and communication are structured, compliant and ready across markets.

Talk to an Expert

What is linguistic validation in clinical trials?

Linguistic validation is the process of confirming that a translated clinical outcome assessment measures the same concept as the source, in the target language and culture. It combines forward and back translation, reconciliation, cognitive debriefing with patients, and a documented audit trail. Regulators and instrument developers expect this evidence when patient-reported data supports a study endpoint.

What are the translation requirements under EU MDR and IVDR?

EU MDR 2017/745 and IVDR 2017/746 require instructions for use, labeling and the summary of safety and clinical performance to be available in the official languages of each member state where the device is placed on the market. Requirements vary by country and device class. Technical documentation must stay consistent and version-controlled across every language.

How are clinical outcome assessments translated for multi-country trials?

A clinical outcome assessment, or COA, captures how a patient feels or functions during a trial. Translating one requires a license from the instrument developer, linguistic validation for each language and country, and screen testing when the questionnaire is delivered on an eCOA device. Platform migration is validated separately from the translation itself.

How are product labels kept consistent across regulatory markets?

Label consistency depends on one approved terminology source, controlled versioning and a documented review step before each market submission. Local labeling requirements differ by authority, so national variations must remain traceable to the approved master. Discrepancies between language versions are a frequent cause of deficiency notices and launch delays.

Is machine translation allowed in regulated Life Sciences content?

No regulation bans machine translation outright, but regulated content must be accurate, traceable and reviewed by a qualified human. In practice it is used with post-editing under ISO 18587, with defined human oversight and a documented audit trail. The risk level of each document type determines how much review it receives.

How is pharmacovigilance documentation translated on regulatory timelines?

Safety reporting runs on fixed regulatory clocks. Individual case safety reports are due within 7 or 15 calendar days depending on severity, and periodic safety update reports follow their own cycle from the data lock point. Translation has to fit inside those windows without breaking version history or the audit trail.

Life Sciences Content Solutions for Global Scale

Why Multilingual Precision Matters in Life Sciences